Zhou Q - Search Results

1

Structure-activity relationship of dual inhibitors containing maleimide and imidazole motifs against glutaminyl cyclase and glycogen synthase kinase-3β.

Wei D, Cai J, Qin F, Zhou Q, Xiong W, Xu C, Li C, Wu H. Wei D, et al. Among authors: zhou q. Bioorg Med Chem Lett. 2024 Sep 15;110:129851. doi: 10.1016/j.bmcl.2024.129851. Epub 2024 Jun 19. Bioorg Med Chem Lett. 2024. PMID: 38906336

2

Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation.

Zhou Q, Cai J, Qin F, Liu J, Li C, Xiong W, Wang Y, Xu C, Wu H. Zhou Q, et al. Bioorg Med Chem. 2024 Jan 1;97:117542. doi: 10.1016/j.bmc.2023.117542. Epub 2023 Dec 6. Bioorg Med Chem. 2024. PMID: 38104495

3

Design, synthesis, and evaluation of 4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidine derivatives as potential glutaminyl cyclase isoenzyme inhibitors for the treatment of cancer.

Zhou Q, Wu Z, Qin F, He P, Wang Z, Zhu F, Gao Y, Xiong W, Li C, Wu H. Zhou Q, et al. Eur J Med Chem. 2025 Jan 5;281:117019. doi: 10.1016/j.ejmech.2024.117019. Epub 2024 Nov 1. Eur J Med Chem. 2025. PMID: 39504793

4

Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A.

Zhou Q, Reekie TA, Abbassi RH, Indurthi Venkata D, Font JS, Ryan RM, Munoz L, Kassiou M. Zhou Q, et al. Bioorg Med Chem. 2018 Dec 1;26(22):5852-5869. doi: 10.1016/j.bmc.2018.10.034. Epub 2018 Oct 28. Bioorg Med Chem. 2018. PMID: 30401502

5

Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors.

Qiu J, Chen W, Zhang Y, Zhou Q, Chen J, Yang L, Gao J, Gu X, Tang D. Qiu J, et al. Among authors: zhou q. Eur J Med Chem. 2019 Aug 15;176:41-49. doi: 10.1016/j.ejmech.2019.05.014. Epub 2019 May 7. Eur J Med Chem. 2019. PMID: 31091479

6

Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.

Qiu J, Zhou Q, Zhang Y, Guan M, Li X, Zou Y, Huang X, Zhao Y, Chen W, Gu X. Qiu J, et al. Among authors: zhou q. Eur J Med Chem. 2020 Nov 1;205:112581. doi: 10.1016/j.ejmech.2020.112581. Epub 2020 Jul 13. Eur J Med Chem. 2020. PMID: 32791397

7

Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.

Gu X, Li X, Guan M, Jiang C, Song Q, Sun N, Zou Y, Zhou Q, Chen J, Qiu J. Gu X, et al. Among authors: zhou q. Bioorg Med Chem Lett. 2020 Dec 15;30(24):127638. doi: 10.1016/j.bmcl.2020.127638. Epub 2020 Oct 22. Bioorg Med Chem Lett. 2020. PMID: 33132117

8

Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.

Gu X, Zhang Y, Zou Y, Li X, Guan M, Zhou Q, Qiu J. Gu X, et al. Among authors: zhou q. Bioorg Med Chem. 2021 Jan 1;29:115892. doi: 10.1016/j.bmc.2020.115892. Epub 2020 Nov 28. Bioorg Med Chem. 2021. PMID: 33285406

9

Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.

Qiu J, Zhou Q, Zou Y, Li S, Yang L, Chen W, Gao J, Gu X. Qiu J, et al. Among authors: zhou q. Eur J Med Chem. 2022 Mar 5;231:114159. doi: 10.1016/j.ejmech.2022.114159. Epub 2022 Jan 29. Eur J Med Chem. 2022. PMID: 35123297

10

Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma.

Liu L, Zhang L, Chen X, Yang K, Cui H, Qian R, Zhao S, Wang L, Su X, Zhao M, Wang M, Hu Z, Lu T, Zhu Y, Zhou QQ, Yao Y. Liu L, et al. Eur J Med Chem. 2023 Dec 5;261:115833. doi: 10.1016/j.ejmech.2023.115833. Epub 2023 Sep 25. Eur J Med Chem. 2023. PMID: 37797564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,479 results

Search Page

Filters